126 related articles for article (PubMed ID: 30522586)
1. Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells.
Izdebska M; Herbet M; Gawrońska-Grzywacz M; Piątkowska-Chmiel I; Korga A; Sysa M; Iwan M; Natorska-Chomicka D; Poleszak E; Wróbel A; Mandziuk S; Dudka J
J Pharm Pharm Sci; 2018; 21(1):504-515. PubMed ID: 30522586
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
[TBL] [Abstract][Full Text] [Related]
3. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
4. Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells.
Jeong HS; Cho YH; Kim KH; Kim Y; Kim KS; Na YC; Park J; Lee IS; Lee JH; Jang HJ
BMC Complement Altern Med; 2016 Jul; 16():239. PubMed ID: 27456850
[TBL] [Abstract][Full Text] [Related]
5. Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention.
Zhang Y; Takemori H; Wang C; Fu J; Xu M; Xiong L; Li N; Wen X
Life Sci; 2017 Mar; 173():107-115. PubMed ID: 28174122
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Treatment Enhances the Cellular Response to Leptin by Increasing OBRb Content in Palmitate-Induced Steatotic HepG2 Cells.
Ardid-Ruiz A; Ibars M; Mena P; Del Rio D; Muguerza B; Arola L; Aragonès G; Suárez M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842467
[TBL] [Abstract][Full Text] [Related]
7. Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.
Poolsri WA; Phokrai P; Suwankulanan S; Phakdeeto N; Phunsomboon P; Pekthong D; Richert L; Pongcharoen S; Srisawang P
Biomed Res Int; 2018; 2018():3683026. PubMed ID: 29546056
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase.
Li S; Bouzar C; Cottet-Rousselle C; Zagotta I; Lamarche F; Wabitsch M; Tokarska-Schlattner M; Fischer-Posovszky P; Schlattner U; Rousseau D
Biochim Biophys Acta; 2016 Jun; 1857(6):643-52. PubMed ID: 26968895
[TBL] [Abstract][Full Text] [Related]
9. Putative identification of components in Zengye Decoction and their effects on glucose consumption and lipogenesis in insulin-induced insulin-resistant HepG2 cells.
Liu Z; Kuang W; Xu X; Li D; Zhu W; Lan Z; Zhang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():145-153. PubMed ID: 29272757
[TBL] [Abstract][Full Text] [Related]
10. The novel resveratrol derivative 3,5-diethoxy-3',4'-dihydroxy-trans-stilbene induces mitochondrial ROS-mediated ER stress and cell death in human hepatoma cells in vitro.
Park JW; Choi WG; Lee PJ; Chung SW; Kim BS; Chung HT; Cho S; Kim JH; Kang BH; Kim H; Kim HP; Back SH
Acta Pharmacol Sin; 2017 Nov; 38(11):1486-1500. PubMed ID: 28795692
[TBL] [Abstract][Full Text] [Related]
11. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
13.
Liu YL; Lin LC; Tung YT; Ho ST; Chen YL; Lin CC; Wu JH
Int J Med Sci; 2017; 14(9):862-870. PubMed ID: 28824323
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
[TBL] [Abstract][Full Text] [Related]
15. A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Olugbami JO; Damoiseaux R; France B; Onibiyo EM; Gbadegesin MA; Sharma S; Gimzewski JK; Odunola OA
BMC Complement Altern Med; 2017 Aug; 17(1):381. PubMed ID: 28768515
[TBL] [Abstract][Full Text] [Related]
16. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.
Szkudelska K; Nogowski L; Szkudelski T
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):17-24. PubMed ID: 19041941
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Prevents Acrylamide-Induced Mitochondrial Dysfunction and Inflammatory Responses via Targeting Circadian Regulator Bmal1 and Cry1 in Hepatocytes.
Tan X; Li L; Wang J; Zhao B; Pan J; Wang L; Liu X; Liu X; Liu Z
J Agric Food Chem; 2019 Aug; 67(31):8510-8519. PubMed ID: 31294559
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease.
Park H; Hwang YH; Kim DG; Jeon J; Ma JY
Nutrients; 2015 Apr; 7(4):2440-55. PubMed ID: 25849950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
